“In pharma, it is better to buy a basket now than individually because select stocks have been outperformers and you want to participate in the whole basket. As a disclosure, Lupin and Aurobindo are two which we have accumulated. We still think that there is upside in both those stocks.”
Subscribe To Our Free Newsletter |